Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI)

Psychopharmacology

Volumn 166, Issue 3, 2003, Pages 294-297

  Eichhammer, Peter ^a   Langguth, Berthold ^a   Wiegand, Rainer ^a   Kharraz, Alexander ^a   Frick, Ulrich ^a   Hajak, Göran ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Motor cortex excitability; Paired pulse transcranial magnetic stimulation; Serotonin gene transporter polymorphism; Serotonin transporter reuptake inhibitor

Indexed keywords

CITALOPRAM; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

ADULT; ALLELISM; ARTICLE; CLINICAL TRIAL; DRUG MECHANISM; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MOTOR CORTEX; NERVE EXCITABILITY; NEUROMODULATION; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; SEROTONINERGIC SYSTEM; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 0037352108     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1370-1     Document Type: Article

References (28)

1. Benkert O, Hippius H (1998) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin Heidelberg
2. Bolden-Watson C, Richelson E (1993) Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 52:1023-1029
3. Carboni E, Tanda GL, Frau R, Di Chiara G (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55:1067-1070
4. Gingrich JA, Hen R (2001) Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology 155:1-10
5. Golembiowska K, Dziubina A (2000) Effect of acute and chronic administration of citalopram on glutamate and aspartate release in the rat prefrontal cortex. Pol J Pharmacol 52:441-448
6. Goodnick PJ, Goldstein BJ (1998) Selective serotonin reuptake inhibitors in affective disorders. I. Basic pharmacology. J Psychopharmacol 12:S5-20
7. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624
8. Ilic TV, Korchounov A, Ziemann U (2002) Complex modulation of human motor cortex excitability by the specific serotonin reuptake inhibitor sertraline. Neurosci Lett 319:116-120
9. Jansen KL, Faull RL, Dragunow M, Leslie RA (1991) Distribution of excitatory and inhibitory amino acid, sigma, monoamine, catecholamine, acetylcholine, opioid, neurotensin, substance P, adenosine and neuropeptide Y receptors in human motor and somatosensory cortex. Brain Res 566:225-238
10. Joubert AF, Sanchez C, Larsen F (2000) Citalopram. Hum Psychopharmacol Clin Exp 15:439-451
11. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531
12. Liepert J, Schardt S, Weiller C (2001) Orally administered atropine enhances motor cortex excitability: a transcranial magnetic stimulation study in human subjects. Neurosci Lett 300:149-152
13. McLaughlin DP, Little KY, Lopez JF, Watson SJ (1996) Expression of serotonin transporter mRNA in human brainstem raphe nuclei. Neuropsychopharmacology 15:523-529
14. Maeda F, Gangitano M, Thall M, Pascual-Leone A (2002) Inter- and intra-individual variability of paired-pulse curves with transcranial magnetic stimulation (TMS). Clin Neurophysiol 113:376-382
15. Pollock BG, Ferrell RE, Mulsant BH, Mazumdar S, Miller M, Sweet RA, Davis S, Kirshner MA, Houck PR, Stack JA, Reynolds CF, Kupfer DJ (2000) Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 23:587-590
16. Price CJ, Pittman QJ (2001) Dopamine D4 receptor activation inhibits presynaptically glutamatergic neurotransmission in the rat supraoptic nucleus. J Neurophysiol 86:1149-1155
17. Rossini PM, Barker AT, Berardelli A, Caramia MD, Caruso G, Cracco RQ, Dimitrijevic MR, Hallett M, Katayama Y, Lucking CH et al. (1994) Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 91:79-92
18. Schwenkreis P, Liepert J, Witscher K, Fischer W, Weiller C, Malin JP, Tegenthoff M (2000) Riluzole suppresses motor cortex facilitation in correlation to its plasma level. A study using transcranial magnetic stimulation. Exp Brain Res 135:293-299
19. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M (1998) Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3:508-511
20. Sommer M, Wu T, Tergau F, Paulus W (2002) Intra- and interindividual variability of motor responses to repetitive transcranial magnetic stimulation. Clin Neurophysiol 113:265-269
21. Stahl SM (2000) Essential psychopharmacology of depression and bipolar disorder. Cambridge University Press, Cambridge
22. Tan JY, Levin GM (1999) Citalopram in the treatment of depression and other potential uses in psychiatry. Pharmacotherapy 19:675-689
23. Van Woert MH, Rosenbaum D, Chung EY (1986) Biochemistry and therapeutics of posthypoxic myoclonus. Adv Neurol 43:171-181
24. Wassermann EM (2002) Variation in the response to transcranial magnetic brain stimulation in the general population. Clin Neurophysiol 113:1165-1171
25. Werhahn KJ, Forderreuther S, Straube A (1998) Effects of the serotonin1B/1D receptor agonist zolmitriptan on motor cortical excitability in humans. Neurology 51:896-898
26. Whale R, Quested DJ, Laver D, Harrison PJ, Cowen PJ (2000) Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine. Psychopharmacology 150:120-122
27. Ziemann U, Hallett M (2000) Basic neurophysiological studies with TMS. In: George MS, Belmaker RH (eds) Transcranial magnetic stimulation in neuropsychiatry. American Psychiatric Press, Washington, D.C., pp 45-98
28. Ziemann U, Tergau F, Bruns D, Baudewig J, Paulus W (1997) Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr Clin Neurophysiol 105:430-437